I call this meeting to order.
Welcome to meeting number 125 of the House of Commons Standing Committee on the Status of Women.
I remind all members of the following points: Please wait until I recognize you by name before speaking, and all comments should be addressed through the chair.
Thank you for your co‑operation.
Pursuant to Standing Order 108(2) and the motions adopted by the committee on Tuesday, June 4, 2024, and Wednesday, September 25, 2024, the committee will continue its study of breast cancer screening.
Before we begin, I ask all in-person participants to read the guidelines written on the updated cards on the table. These measures are in place to help prevent audio and feedback incidents and to protect the health and safety of all participants, including the interpreters.
Welcome to our witnesses.
Appearing as individuals we have Dr. Anna Wilkinson, medical doctor; Julie McIntyre, by video conference; Dr. Paula Gordon, clinical professor of radiology, by video conference; and Dr. Shiela Appavoo, radiologist, by video conference.
From Breast Cancer Canada we have Kim MacDonald, patient advocate. From Breast Cancer Action Quebec we have Jennifer Beeman, research and advocacy adviser, by video conference; and Milena Gioia, coordinator, programs and advocacy, by video conference. From the Quebec Breast Cancer Foundation we have Karine-Iseult Ippersiel, president and chief executive officer.
We begin with opening statements.
Dr. Wilkinson, you have the floor for up to five minutes.